Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • 5-HT Receptor
    (48)
  • Apoptosis
    (38)
  • ADC Linker
    (37)
  • Endogenous Metabolite
    (35)
  • Antibacterial
    (25)
  • Adrenergic Receptor
    (18)
  • Antifection
    (17)
  • Autophagy
    (17)
  • Calcium Channel
    (17)
  • Others
    (915)
Filter
Search Result
Results for "

high

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1904
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    112
    TargetMol | Compound_Libraries
  • Peptide Products
    212
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    62
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    178
    TargetMol | Dye_Reagents
  • PROTAC Products
    22
    TargetMol | PROTAC
  • Natural Products
    177
    TargetMol | Natural_Products
  • Reagent Kits
    50
    TargetMol | Reagent_Kits
  • Recombinant Protein
    468
    TargetMol | Recombinant_Protein
  • Isotope Products
    20
    TargetMol | Isotope_Products
  • Antibody Products
    25
    TargetMol | Antibody_Products
  • Disease Modeling
    5
    TargetMol | Disease_Modeling_Products
Terazosin hydrochloride
Zayasel, Terazosine, Terazosin HCl, Hytrin, Fosfomic, Blavin
T019763074-08-8
Terazosin hydrochloride (Hytrin) , a selective alpha1-antagonist, can treat the benign prostatic hyperplasia (BPH). It also can lower blood pressure, so it is a drug of choice for patients with prostate enlargement and hypertension. It works on the smooth muscle of the bladder and the blood vessel walls by blocking the function of adrenaline.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Verapamil hydrochloride
Verapamil HCl, Manidon, Calcan hydrochloride, (±)-Verapamil hydrochlorid
T1010152-11-4
Verapamil hydrochloride (Verapamil HCl) is a calcium channel blocker that is a class IV anti-arrhythmia agent.
  • Inquiry Price
Size
QTY
Verapamil
NSC-135784, NSC 135784, CP-16533-1, (±)-Verapamil
T2065652-53-9
Verapamil (CP-16533-1) is a calcium channel blocker and an orally active and effective inhibitor of P-gp. Verapamil inhibits CYP3A4 and can be used in studies about the treatment of high blood pressure, heart arrhythmias, and angina research.
  • Inquiry Price
4-6 weeks
Size
QTY
TargetMol | Citations Cited
28-high brassinolide
T846582373-95-3
28-high brassinolide is a natural product for research related to life sciences. The catalog number is T8465 and the CAS number is 82373-95-3.
  • Inquiry Price
Size
QTY
RMC-9805
Zoldonrasib, KRAS G12D inhibitor 18, KRAS G12D IN 18
T782122922732-54-3
RMC-9805 is a novel, mutant-selective, covalent and oral KRASG12D (ON) inhibitor. A stable and high affinity triple complex is formed between RMC-9805, KRASG12D, and cyclophilin A, which inhibits signal transduction downstream of KRASG12D (ON) by disrupting its interaction with downstream effectors. RMC-9805 can induce cell apoptosis and promote tumor regression in preclinical KRASG12D tumor models. With rich experience in compound synthesis, we can provide fast customized synthesis services for this product according to your research needs.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Trastuzumab
T9912180288-69-1
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Iptacopan hydrochloride
LNP023 hydrochloride, Iptacopan HCl
T91891646321-63-2In house
Iptacopan hydrochloride (LNP023 hydrochloride) is an orally bioavailable, highly potent and highly selective factor B inhibitor with an IC50 of 10 nM. Iptacopan hydrochloride shows direct, reversible, and high-affinity binding to human factor B with a KD of 7.9 nM.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
BMS-1
PD1-PDL1 inhibitor 1, PD-1 PD-L1 inhibitor 1
T36551675201-83-8
BMS-1 (PD-1 PD-L1 inhibitor 1) is an inhibitor of the PD1-PD-L1 protein-protein interaction. It also acts as an immunomodulator. Programmed death ligand 1 (PD-L1) is a protein in humans that is encoded by the CD274 gene and the upregulation of PD-L1 allows Ys to evade the host immune system. High tumor expression of PD-L1 was associated with increased tumor aggressiveness and a 4.5-fold increased risk of death.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Calf thymus DNA
DNA from calf thymus, Thymonucleic acid
T1359291080-16-9
Calf thymus DNA (DNA from calf thymus, Thymonucleic acid) is a high-quality double-stranded template DNA extracted from the bovine thymus gland, widely used in studying DNA binding anticancer agents and DNA binding agents that regulate DNA structure and function.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Adavivint
Adavivint (SM04690)
T56361467093-03-3
Adavivint (SM04690) is a selective inhibitor of the typical Wnt signaling pathway. In SW480 cells, EC50=19.5 nM was measured using high-throughput TCF LEF reporter gene experiments.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Bevacizumab
T9904216974-75-3
Bevacizumab, a humanized monoclonal antibody, specifically and with high affinity binds to all isoforms of VEGF-A.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Balsalazide disodium dihydrate
T4615150399-21-6
Balsalazide sodium hydrate (Balsalazide disodium) is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.Balsalazide sodium hydrate is a new 5-aminosalicylic acid (5-ASA) containing prodrug. High dose Balsalazide sodium hydrate(3.0 g twice daily) was superior in maintaining remission in patients with ulcerative colitis compared with a low dose (1.5 g twice daily) or a standard dose of mesalazine (0.5 g three times daily). All three treatments were safe and well tolerated [1]. Balsalazide sodium hydrate is approved for the treatment of mild-to-moderate active UC. It is efficacious for the induction of remission in mild to moderate UC and has a favorable safety profile, with the added advantages of greater efficacy of remission induction and rapidity of onset [2].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Quizartinib
AC220
T2066950769-58-1
Quizartinib (AC220) is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
5-HT1A modulator 1
5-HT1Amodulator1
T10168142477-34-7In house
5-HT1A modulator 1 exhibits high affinities for the 5-HT1A, α1-adrenergic receptor, and D2 receptor (IC50s = 2 nM, 10 nM, and 40 nM).
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Hot
Pancreatic Polypeptide, rat acetate
TP1044L
Pancreatic Polypeptide, rat acetate is an agonist of NPY receptor, with high affinity at NPYR4.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
GSK484 hydrochloride
GTPL8577, AOB6992
TQ00671652591-81-5
GSK484 hydrochloride (GTPL8577) is a reversible peptidyl-arginine deiminase 4 (PAD4) inhibitor. It binds to PAD4 with high affinity, with IC50 of 250 and 50 nM in the presence and absence of 2 mM calcium, respectively. GSK484 promotes the radiosensitivity of colorectal cancer (CRC) and inhibits NET formation in vitro and in vivo.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Iptacopan
LNP023
T118641644670-37-0
Iptacopan (LNP023) is an inhibitor with high affinity to factor B, with a KD value of 7.9 nM and an IC50 value of 10 nM.
  • Inquiry Price
8-10 weeks
Size
QTY
TargetMol | Inhibitor Hot
divarasib
GDC-6036
T99722417987-45-0
Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 μM. Divarasib irreversibly locks KRAS G12C oncoprotein in an inactive state and inhibits tumor cell growth. It is being investigated for use in solid tumors, including non-small cell lung and colorectal cancers and other types of cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Ritobegron HCl
Ritobegron hydrochloride, KUC-7483, KUC7483, KUC 7483
T34333476333-91-2In house
Ritobegron (KUC-7483), an effective and selective β3-adrenergic receptor agonist, shows effective β(3)-AR agonist activity on transfected human β-AR and has an effect on the bladder of rats Shows high selectivity with other organs.
  • Inquiry Price
3-6 months
Size
QTY
Dual FAAH/sEH-IN-1
T635362756099-59-7In house
Dual FAAH sEH-IN-1 is a dual inhibitor of sEH (soluble epoxide hydrolase) (IC50: 9.6 nM) and FAAH (fatty acid amide hydrolase) (IC50: 7 nM) with high affinity and anti-inflammatory activity.
  • Inquiry Price
10-14weeks
Size
QTY
TargetMol | Inhibitor Sale
TargetMol
RMM-46
RMM46
T261031307896-46-3In house
RMM-46 is a reversible covalent inhibitor with high ligand efficiency and selectivity for MSK RSK family kinases.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Citations Cited
ULK1-IN-2
T633432497409-01-3In house
ULK1-IN-2 is a potent ULK1 inhibitor with potential anticancer activity, inducing apoptosis while blocking autophagy.ULK1-IN-2 has high cytotoxicity against cancer cells, with an IC50 value of 1.94 μM against A549 cells.ULK1-IN-2 can be used for the study of non-small-cell lung cancer.
  • Inquiry Price
6-8 weeks
Size
QTY
Zifaxaban
TY 602, TY602, TY-602
T292151378266-98-8In house
Zifaxaban (TY-602) is an orally active, competitive and selective inhibitor of factor Xa (FXa) with an IC50 of 11.1 nM for human FXa.Zifaxaban has a very high affinity, more than 10,000-fold higher than that of other serine proteases.Zifaxaban can be used to study arterial and venous thrombosis.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
PPTN
T125301160271-30-6In house
PPTN is a high-affinity, competitive and highly selective antagonist of P2Y14 receptor(KB value of 434 pM), with anti-inflammatory and immune activity.
  • Inquiry Price
6-8 weeks
Size
QTY